# TAFA5

## Overview
TAFA5, or Family with sequence similarity 19-member a5, is a gene that encodes the TAFA chemokine-like family member 5 protein. This protein is part of the TAFA family, which consists of small secreted proteins predominantly expressed in the central nervous system. TAFA5 is evolutionarily related to the macrophage inflammatory protein 1A, a member of the small c-c chemokine family, and is involved in various physiological processes, including fluid homeostasis, kidney development, and bone metabolism (Hu2019TAFA5). The protein functions by interacting with G-protein-coupled receptors such as formyl peptide receptor 2 (FPR2) and sphingosine-1-phosphate receptor 2 (S1PR2), influencing chemotaxis and other cellular processes (Sarver2021FAM19A). TAFA5's role in both immune and cancer-related pathways highlights its potential as a therapeutic target, particularly in conditions like gastric cancer and neuroinflammatory disorders (Hu2019TAFA5; Sarver2021FAM19A).

## Function
TAFA5, also known as Family with sequence similarity 19-member a5, is part of the TAFA family, which includes small secreted proteins primarily expressed in the central nervous system. These proteins are evolutionarily related to macrophage inflammatory protein 1A, a member of the small c-c chemokine family (Hu2019TAFA5). In healthy human cells, TAFA5 is involved in several physiological processes. It colocalizes with vasopressin and oxytocin in the hypothalamic paraventricular nucleus, suggesting a role in fluid homeostasis regulation (Hu2019TAFA5). TAFA5 is also a downstream target of Wnt family member 9b and can be activated by interactions between c-Myc and β-catenin, which induces Wnt9b/β-catenin-mediated progenitor renewal in the developing kidney (Hu2019TAFA5).

In the skeletal system, TAFA5 inhibits osteoclast formation by interacting with its receptor, formyl peptide receptor 2 (FPR2), and stimulating bone marrow-derived macrophages (Sarver2021FAM19A). This function suggests a role in bone metabolism. TAFA5's involvement in these processes indicates its importance in maintaining physiological balance in fluid regulation, kidney development, and bone metabolism in healthy human cells (Hu2019TAFA5).

## Clinical Significance
Alterations in the expression of the TAFA5 gene have been implicated in several diseases, particularly in the context of cancer and neurological disorders. In gastric cancer, TAFA5 is significantly upregulated in tumor tissues compared to normal tissues. This overexpression is associated with poor differentiation and advanced tumor stages, correlating with unfavorable patient prognoses. High TAFA5 expression promotes proliferation and migration in gastric cancer cells, suggesting its role in tumor aggressiveness and potential as a therapeutic target (Hu2019TAFA5).

In glioblastoma multiforme, a regional gain in the TAFA5 gene has been identified, suggesting its potential role as a disease-predisposing factor. This gain is not observed in normal individuals, indicating a specific alteration in glioblastoma cases (de2005Chromosome).

TAFA5 is also involved in neuroinflammatory conditions. Its expression is upregulated in response to inflammatory stimuli, such as TNF-α and traumatic brain injury. Knockout studies in mice have shown that loss of TAFA5 leads to depressive-like behaviors and impaired spatial learning, highlighting its potential relevance to human depression and cognitive impairment (Huang2020FAM19A5TAFA5; Sarver2021FAM19A).

## Interactions
TAFA5, also known as FAM19A5, interacts with specific receptors and plays a role in various cellular processes. It binds to formyl peptide receptor 2 (FPR2) and sphingosine-1-phosphate receptor 2 (S1PR2). The interaction with FPR2 can be inhibited by an FPR2 antagonist, while its binding to S1PR2 can be blocked by either an unlabeled FAM19A5 or its natural ligand, sphingosine-1-phosphate (S1P) (Sarver2021FAM19A). These interactions suggest that TAFA5 acts through G-protein-coupled receptors (GPCRs), influencing processes such as chemotaxis in bone marrow-derived macrophages (BMDMs) (Sarver2021FAM19A).

In the context of gastric cancer, TAFA5 is implicated in promoting epithelial-mesenchymal transition (EMT) by interacting with pathways involving EMT transcription factors. Although its association with the Wnt/β-catenin signaling pathway is weak, TAFA5 may interact with Wnt9a and Wnt9b, indicating a potential role in Wnt9b/β-catenin-mediated processes (Hu2019TAFA5). These interactions highlight TAFA5's involvement in both immune and cancer-related pathways, suggesting its potential as a therapeutic target. However, specific interactions with other proteins or nucleic acids beyond these receptors are not well-documented in the current literature.


## References


[1. (de2005Chromosome) Teresita Díaz de Ståhl, Christian Hartmann, Cecilia de Bustos, Arkadiusz Piotrowski, Magdalena Benetkiewicz, Kiran K. Mantripragada, Tomasz Tykwinski, Andreas von Deimling, and Jan P. Dumanski. Chromosome 22 tiling‐path array–cgh analysis identifies germ‐line‐ and tumor‐specific aberrations in patients with glioblastoma multiforme. Genes, Chromosomes and Cancer, 44(2):161–169, June 2005. URL: http://dx.doi.org/10.1002/gcc.20226, doi:10.1002/gcc.20226. This article has 30 citations.](https://doi.org/10.1002/gcc.20226)

[2. (Huang2020FAM19A5TAFA5) Shiyang Huang, Can Zheng, Guoguang Xie, Zhanming Song, Pingzhang Wang, Yun Bai, Dixin Chen, Yan Zhang, Ping Lv, Weiwei Liang, Shaoping She, Qingqing Li, Zhongtian Liu, Yun Wang, Guo-Gang Xing, and Ying Wang. Fam19a5/tafa5, a novel neurokine, plays a crucial role in depressive-like and spatial memory-related behaviors in mice. Molecular Psychiatry, 26(6):2363–2379, April 2020. URL: http://dx.doi.org/10.1038/s41380-020-0720-x, doi:10.1038/s41380-020-0720-x. This article has 29 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41380-020-0720-x)

[3. (Hu2019TAFA5) Zhiqing Hu, Gengming Niu, Jun Ren, Xin Wang, Liang Chen, Runqi Hong, and Chongwei Ke. Tafa5 promotes proliferation and migration in gastric cancer. Molecular Medicine Reports, October 2019. URL: http://dx.doi.org/10.3892/mmr.2019.10724, doi:10.3892/mmr.2019.10724. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/mmr.2019.10724)

[4. (Sarver2021FAM19A) Dylan C. Sarver, Xia Lei, and G. William Wong. Fam19a (tafa): an emerging family of neurokines with diverse functions in the central and peripheral nervous system. ACS Chemical Neuroscience, 12(6):945–958, February 2021. URL: http://dx.doi.org/10.1021/acschemneuro.0c00757, doi:10.1021/acschemneuro.0c00757. This article has 16 citations and is from a peer-reviewed journal.](https://doi.org/10.1021/acschemneuro.0c00757)